12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021 Event
Go back to 12-Month Data from Surmodics’ TRANSCEND Trial Presented at LINC 2021 Event| Abbott Laboratories (NYSE: ABT) | Delayed: 112.68 +2.31 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.37 | 52 Week High | $46.38 | |||
| Open | $112.45 | 52 Week Low | $36.00 | |||
| Day High | $113.63 | P/E | 75.12 | |||
| Day Low | $111.75 | EPS | $1.50 | |||
| Volume | 9,781,731 | |||||
| SurModics, Inc. (NASDAQ: SRDX) | Delayed: 42.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.98 | 52 Week High | $30.75 | |||
| Open | $42.98 | 52 Week Low | $17.45 | |||
| Day High | $42.98 | P/E | 44.31 | |||
| Day Low | $42.98 | EPS | $0.97 | |||
| Volume | 81,948 | |||||
